News - Orfadin

Filter

Current filters:

Orfadin

Popular Filters

Sobi terminates deal with Rare Disease Therapeutics for Orfadin distribution

Sobi terminates deal with Rare Disease Therapeutics for Orfadin distribution

20-12-2013

Nordic biotech firm Swedish Orphan Biovitrum (STO: SOBI) has terminated its distributor agreement with…

BiotechnologyLegalLicensingNorthern EuropeOrfadinRare Disease TherapeuticsSobi

SOBI reveals strong sales in third quarter

SOBI reveals strong sales in third quarter

30-10-2013

Swedish Orphan Biovitrum has published its third quarter results revealing that total revenues were 517.3…

EuropeFinancialKineretOrfadinPharmaceuticalSobi

SOBI files for Orfadin oral suspension with EMA

22-08-2013

Swedish Orphan Biovitrum (STO: SOBI) said this morning (August 22) that the company's application for…

EuropeOrfadinPharmaceuticalRare diseasesRegulationSwedish Orphan Biovitrum

Back to top